You are here

Vascular & Endovascular

 

The FDA on Feb. 15 announced Stryker’s Trevo Retriever clot-removal device can be used up to 24 hours after stroke onset, mirroring the American Heart Association and American Stroke Association’s recently updated guidelines expanding the window for mechanical thrombectomy from 6 to 24 hours.

The FDA cleared Viz.ai’s clinical support tool on Feb. 13, allowing the software that alerts clinicians to the possibility of a stroke to be marketed in the United States.

Short kids grow up to have a higher risk of stroke, according to a study of more than 310,000 Danish schoolchildren with up to eight decades of follow-up.

A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).

People who have migraines are more at risk than the general population for a range of adverse cardiovascular events, according to a study published in The BMJ.

 

Recent Headlines

FDA: Trevo clot remover OK up to 24 hours after stroke

The FDA on Feb. 15 announced Stryker’s Trevo Retriever clot-removal device can be used up to 24 hours after stroke onset, mirroring the American Heart Association and American Stroke Association’s recently updated guidelines expanding the window for mechanical thrombectomy from 6 to 24 hours.

FDA clears AI platform that quickly alerts specialists to strokes

The FDA cleared Viz.ai’s clinical support tool on Feb. 13, allowing the software that alerts clinicians to the possibility of a stroke to be marketed in the United States.

Short kids more likely to experience stroke in adulthood

Short kids grow up to have a higher risk of stroke, according to a study of more than 310,000 Danish schoolchildren with up to eight decades of follow-up.

Researchers develop stroke risk score for patients with MI, heart failure—but not AFib

A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).

Study links migraines to several cardiovascular diseases—especially stroke

People who have migraines are more at risk than the general population for a range of adverse cardiovascular events, according to a study published in The BMJ.

10 things to know about the intersection of breast cancer, CVD

When a woman receives a breast cancer diagnosis, she likely isn’t thinking about her heart health. But, experts at the American Heart Association (AHA) say, she probably should be.

Researchers debunk medicine's 'July phenomenon' in stroke patients

A group of researchers are further disproving medicine’s “July phenomenon”—the myth that clinical care suffers in the summertime due to an influx of new hospital residents—with a study of nearly one million acute ischemic stroke patients.

NOACs superior to warfarin for outcomes after intracerebral hemorrhage

Compared to patients who used warfarin prior to experiencing intracerebral hemorrhage, those who took non-vitamin K oral anticoagulants (NOACs) were 25 percent less likely to die in the hospital, according to a study in the Journal of the American Medical Association.

Psychiatric patients less likely to receive thrombolysis following stroke

Patients with psychiatric diseases are 20 percent less likely to receive intravenous thrombolysis (IVT), an evidence-based therapy for improving outcomes after ischemic stroke, researchers from Johns Hopkins University reported in Stroke.

More than 10% of stroke patients still can't afford meds under ACA

Though federal initiatives to expand health coverage under the Affordable Care Act (ACA) have been successful, more than one in 10 stroke survivors are still unable to afford their medication, experts reported at last week’s International Stroke Conference in Los Angeles.

Pages